Related Experiment Videos
Field matching considerations in craniospinal irradiation.
1Quality Assurance Review Center, Rhode Island Hospital, Providence 02903.
International Journal of Radiation Oncology, Biology, Physics
|October 1, 1989
Summary
Gapping radiotherapy fields in craniospinal axis treatments creates underdosage, compromising treatment uniformity. Proper field matching ensures dose accuracy, crucial for leukemia and medulloblastoma patients.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Craniospinal axis radiotherapy commonly uses parallel-opposed lateral cranial fields adjacent to a posterior spinal field.
- Treatment protocols often require cranial field rotation to match diverging spinal fields, creating a junction in the mid-sagittal plane.
- Some centers implement gaps between fields to prevent spinal cord overdosing.
Purpose of the Study:
- To investigate the dose distribution in the junction region of divergence-compensated radiotherapy fields with varying separations (overlap to gap).
- To evaluate the impact of field gapping and feathering techniques on dose uniformity in craniospinal radiotherapy.
Main Methods:
- Calculated composite dose profiles and isodose maps for 60Co and 4 MV photon beams.
- Simulated field separations ranging from 0.5 cm overlap to a 1 cm gap.
- Assessed static and moving junction (feathering) techniques.
Main Results:
- Appropriate field matching without gaps results in smooth dose variation across the junction.
- Gapping divergence-compensated fields leads to detrimental underdosage throughout the treatment volume.
- Spinal cord myelopathy dose is unlikely to be exceeded in leukemia patients with proper setup; it may occur in medulloblastoma patients with significant field overlap.
Conclusions:
- Field gapping in craniospinal radiotherapy compromises dose uniformity and is generally detrimental.
- Proper field matching and localization are essential for accurate dose delivery.
- Feathering may offer a safety margin for medulloblastoma but is unnecessary for leukemia, emphasizing the need for quality assurance and precise patient setup.